Osteoporosis and fractures in Turner syndrome–importance of growth promoting and oestrogen therapy
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Turner syndrome (TS) is a chromosomal aberration (45,X) characterized by endogenous oestrogen deficiency and short stature. The aim was to study body composition, bone mineral density, fracture frequency, social and life style factors and biochemical bone markers, as well as hormones, in adults with TS in comparison with a female random population sample. PATIENTS: Seventy women with TS responded to questionnaires. They underwent physical examination, bone mineral density measurement with Dual Energy X‐ray Absorptiometry (DEXA) and blood sampling. Mean age was 31 ± 12 (range 16–71) years. A random population sample of women from the WHO MONICA Project, Göteborg (25–64 years) served as controls (n = 740). RESULTS: Women with TS were shorter than the controls and had lower body weight and lean body mass (P < 0.0001). Body mass index and waist/hip circumference ratio were higher in TS (P < 0.0001). Osteoporosis was present in seven TS women, six above 45 years of age. None of these had received oestrogen substitution continuously. Fractures (all types) were reported by 11 (16%) TS women (six (50%) above 45 years) compared with 5% in the population sample (P < 0.001). Four TS women with fractures had osteoporosis, all above 45 years of age. Osteoporosis and fractures did not differ between women with the 45,X karyotype and those with mosaicism. Impaired hearing was reported by 40%, and 73% wore glasses. Six percent among TS were smokers compared with 25% in the population (P < 0.001). TS women reported a lower degree of leisure time physical activity than controls (P < 0.001). Parathyroid hormone and osteocalcin were higher among TS (P < 0.02 and 0.001). Insulin‐like growth factor‐I was similar. Ninety‐one percent of all TS had oestrogen substitution and 96% of TS below 25 years of age had received growth hormone treatment. CONCLUSION: Osteoporosis and fractures were common above, but not below, 45 years of age in Turner syndrome. It is probable that modern therapy, including growth promoting and continuous oestrogen therapy, will prevent osteoporotic fractures in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dr. Ho, K. K. Y., & Weissberger, A. J. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070711 · Cited by 91 · cited 1×
“GH and oestrogen have synergistic effects on bone tissue (Ho & Weissberger, 1992).”
Background
Cited by
Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101
Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group
Bondy, C. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1374 · Cited by 1,005
“If BMD is low in a young woman with TS, one needs to investigate and treat possible contributory factors such estrogen replacement noncompliance, tobacco use, excessive alcohol use, possible celiac disease, or vitamin D deficiency.”
InfluentialSybert, V. P., & McCauley, E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030360 · Cited by 929
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Turner’s Syndrome in Adulthood
Elsheikh, M., Dunger, D. B., Conway, G. S., & Wass, J. A. H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0457 · Cited by 399
Metadata
- Authors
- Landin‐Wilhelmsen, K., Bryman, I., Windh, M., & Wilhelmsen, L.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1999-10
- Volume
- 51
- Issue
- 4
- Pages
- 497-502
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2024866744
- Cited by
- 157
- References
- 1
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Osteoporosis and fractures in Turner syndrome–importance of growth promoting and oestrogen therapy. https://app.cochat.ai/papers/10.1046/j.1365-2265.1999.00841.x
- The paper
- Landin‐Wilhelmsen, K., Bryman, I., Windh, M., & Wilhelmsen, L. (1999). Osteoporosis and fractures in Turner syndrome–importance of growth promoting and oestrogen therapy. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1999.00841.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.